Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
pfizer
19
×
life sciences
national blog main
national top stories
san diego blog main
san diego top stories
boston blog main
boston top stories
new york blog main
new york top stories
san francisco blog main
biotech
national
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
clinical trials
startups
abbvie
alzheimer's disease
cancer
deals
medicare
merck
novartis
president trump
astrazeneca
What
drug
19
×
bio
pfizer
roundup
week
fda
approved
ceo
medicine
alnylam
alzheimer’s
announced
disease
help
medical
new
news
patients
prescription
prices
year
acquisitions
biggest
biogen
biotech
cancer
chantix
companies
company
discovery
europe
gene
gets
nash
people
pharmaceutical
plan
popular
read
recall
Language
unset
unknown
Current search:
pfizer
×
drug
×
@bgr.com
2 years ago
If you take this popular prescription medicine, stop immediately and read this
@bgr.com
2 years ago
If you take this popular prescription medication, stop right now and call your doctor
@bgr.com
3 years ago
Coronavirus vaccinations to start as soon as Monday, but Pfizer drug supply will be limited
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@SeverineLienard
7 years ago
[#AI] #IBMWatson & Pfizer join forces on cancer drug discovery http://buff.ly/2g78CV3 #BigData #Health… https://twitter.com/i/web/status/805647928715079681
@techcrunch.com
8 years ago
IBM, Pfizer launch joint experiment to help measure Parkinson’s symptoms using IoT and analytics